Ro52‐ and Ro60‐specific B cell pattern in the salivary glands of patients with primary Sjögren's syndrome

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Clinical and Experimental Immunology

• Publication date

  2013-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/cei.12058PMID 23574319PMCID PMC3628325
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autoantigen‐Specific Memory B Cells in Primary Sjögren’s Syndrome

  2012cited by this paper
• Germinal Center B-cells

  2012cited by this paper
• Topical and systemic medications for the treatment of primary Sjögren's syndrome

  2012cited by this paper
• B cells in Sjögren's syndrome: from pathophysiology to diagnosis and treatment.

  2012cited by this paper
• Low number of memory B cells in the salivary glands of patients with primary Sjögren's syndrome

  2012cited by this paper
• Anti-Ro and anti-La autoantibody profiling in Norwegian patients with primary Sjögren’s syndrome using luciferase immunoprecipitation systems (LIPS)

  2012cited by this paper
• Salivary glands of primary Sjögren's syndrome patients express factors vital for plasma cell survival

  2011cited by this paper
• Phenotypic Diversity of Peripheral Blood Plasma Cells in Primary Sjögren’s Syndrome

  2011cited by this paper
• Distinct phenotypes of plasma cells in spleen and bone marrow of autoimmune NOD.B10.H2b mice

  2011cited by this paper
• Isolation of Human B Cell Populations

  2011cited by this paper
• The complexity of Sjögren's syndrome: novel aspects on pathogenesis.

  2011cited by this paper
• Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response

  2009cited by this paper
• Sjögren’s syndrome patients presenting with hypergammaglobulinemia are relatively unresponsive to cevimeline treatment

  2009cited by this paper
• Anti‐CD20 treatment in Primary Sjögren’s Syndrome

  2008cited by this paper
• Serological implications of germinal center-like structures in primary Sjögren's syndrome.

  2007cited by this paper
• B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue

  2007cited by this paper
• Role of B cells in Sjögren's syndrome--from benign lymphoproliferation to overt malignancy.

  2007cited by this paper
• Detection of antigen specific B-cells in tissues.

  2007cited by this paper
• Differential expression of Ro/SSA 60 kDa and La/SSB, but not Ro/SSA 52 kDa, mRNA and protein in minor salivary glands from patients with primary Sjögren's syndrome.

  2007cited by this paper
• Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE.

  2007cited by this paper
• Sjögren's Syndrome—A Plethora of Clinical and Immunological Phenotypes with a Complex Genetic Background

  2007cited by this paper
• B lymphocytes on the front line of autoimmunity.

  2006cited by this paper
• B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles.

  2006cited by this paper
• Isolation of Human B Cell Populations

  2006cited by this paper
• The serological pattern of autoantibodies to the Ro52, Ro60, and La48 autoantigens in primary Sjögren's syndrome patients and healthy controls

  2005cited by this paper
• Abnormalities in peripheral B cell memory of patients with primary Sjögren's syndrome.

  2004cited by this paper
• In Multiple Myeloma Clonotypic CD38 − /CD19 + /CD27 +  Memory B Cells Recirculate Through Bone Marrow, Peripheral Blood and Lymph Nodes

  2004cited by this paper
• Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome.

  2003cited by this paper
• Local production of Ro/SSA and La/SSB autoantibodies in the target organ coincides with high levels of circulating antibodies in sera of patients with Sjögren's syndrome

  2003cited by this paper
• Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

  2002cited by this paper
• Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome.

  2002cited by this paper
• Abnormal B cell differentiation in primary Sjögren's syndrome results in a depressed percentage of circulating memory B cells and elevated levels of soluble CD27 that correlate with Serum IgG concentration.

  2002cited by this paper
• Change in final diagnosis on second evaluation of labial minor salivary gland biopsies.

  2002cited by this paper
• Chemokines and the tissue-specific migration of lymphocytes.

  2002cited by this paper
• Bm1–Bm5 Classification of Peripheral Blood B Cells Reveals Circulating Germinal Center Founder Cells in Healthy Individuals and Disturbance in the B Cell Subpopulations in Patients with Primary Sjögren’s Syndrome1

  2001cited by this paper
• Autoantibodies in Primary Sjögren's Syndrome: New Insights into Mechanisms of Autoantibody Diversification and Disease Pathogenesis

  2001cited by this paper
• Reproducibility of biopsy grade in Sjögren's syndrome.

  2001cited by this paper
• Significantly Depressed Percentage of CD27+ (Memory) B Cells among Peripheral Blood B Cells in Patients with Primary Sjögren's Syndrome

  2001cited by this paper
• B‐1 cells: the lineage question revisited

  2000cited by this paper
• CD27: a memory B-cell marker.

  2000cited by this paper
• Regulation of CD27 expression in the course of germinal center B cell differentiation: the pivotal role of IL‐10

  2000cited by this paper
• Ro/SS‐A‐reactive B lymphocytes in salivary glands and peripheral blood of patients with Sjögren's syndrome

  1999cited by this paper
• Human Immunoglobulin (Ig)M+IgD+ Peripheral Blood B Cells Expressing the CD27 Cell Surface Antigen Carry Somatically Mutated Variable Region Genes: CD27 as a General Marker for Somatically Mutated (Memory) B Cells

  1998cited by this paper
• Humoral immunity due to long-lived plasma cells.

  1998cited by this paper
• Bone marrow is a major site of long-term antibody production after acute viral infection

  1995cited by this paper
• Sjögren's syndrome

  1995cited by this paper
• Analysis of somatic mutation in five B cell subsets of human tonsil

  1994cited by this paper
• Human IgM+IgD+ B cells, the major B cell subset in the peripheral blood, express Vϰ genes with no or little somatic mutation throughout life

  1993cited by this paper
• Maintenance of B-cell memory by long-lived cells generated from proliferating precursors

  1990cited by this paper
• Human immunoglobulin A.

  1968cited by this paper

• Deciphering Sjögren's disease: New insights and perspectives extend from advanced omics approaches and immunology.

  2026cites this paper
• Salivary gland organoids and the future of modeling autoimmune epithelitis in Sjögren's disease.

  2025cites this paper
• A cross-sectional observational study of patients with sicca with salivary autoantibodies defines a potential new phenotype of Sjögren's disease.

  2025cites this paper
• How to focus on autoantigen-specific lymphocytes: a review on diagnosis and treatment of Sjogren's syndrome.

  2025cites this paper
• Roles of TRIM21/Ro52 in connective tissue disease-associated interstitial lung diseases

  2024cites this paper
• Heterogeneity of antibody-secreting cells infiltrating autoimmune tissues

  2023cites this paper
• Sjögren’s syndrome: novel insights from proteomics and miRNA expression analysis

  2023cites this paper
• Expression sites of immunohistochemistry markers in oral diseases – A scoping review

  2022cites this paper
• An updated review of anti-Ro52 (TRIM21) antibodies impact in connective tissue diseases clinical management.

  2021cites this paper
• Anti-Ro52 antibody is highly prevalent and a marker of better prognosis in patients with ovarian cancer.

  2021cites this paper
• CP-25 alleviates antigen-induced experimental Sjögren’s syndrome in mice by inhibiting JAK1-STAT1/2-CXCL13 signaling and interfering with B-cell migration

  2020cites this paper
• A Novel Proposal of Salivary Lymphocyte Detection and Phenotyping in Patients Affected by Sjogren’s Syndrome

  2020cites this paper
• Expression of NGAL-specific cells and mRNA levels correlate with inflammation in the salivary gland, and its overexpression in the saliva, of patients with primary Sjögren’s syndrome

  2020cites this paper
• Contributions of Major Cell Populations to Sjögren’s Syndrome

  2020cites this paper
• Biologic therapy in Sjögren’s syndrome

  2020cites this paper
• Efficacy and safety of iguratimod on patients with primary Sjögren’s syndrome: a randomized, placebo-controlled clinical trial

  2020cites this paper
• University of Birmingham Phosphatidylinositol 3-kinase delta pathway

  2019cites this paper
• B cell dysregulation in primary Sjögren’s syndrome: A review

  2019cites this paper
• Autoantigen-specific B cells and plasma cells are prominent in areas of fatty infiltration in salivary glands of patients with primary Sjögren’s syndrome

  2019cites this paper
• Rescue of autophagy and lysosome defects in salivary glands of MRL/lpr mice by a therapeutic phosphopeptide.

  2018cites this paper
• Relapsed/refractory acquired thrombotic thrombocytopenic purpura in a patient with Sjögren syndrome

  2018cites this paper
• A review of the role and clinical utility of anti-Ro52/TRIM21 in systemic autoimmunity

  2017cites this paper
• Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren’s syndrome

  2016cites this paper
• Invariant NKT cells are expanded in peripheral blood but are undetectable in salivary glands of patients with primary Sjögren's syndrome.

  2016cites this paper
• AUTOANTIGEN-SPECIFIC B CELLS ARE PROMINENT IN AREAS OF FATTY INFILTRATION IN SALIVARY GLANDS OF PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME

  2015cites this paper
• Refractory primary Sjögren syndrome successfully treated with bortezomib.

  2015cites this paper
• Interaction between innate immunity and Ro52-induced antibody causes Sjögren's syndrome-like disorder in mice

  2015cites this paper
• Células B como blanco de terapias en síndrome de Sjögren

  2014cites this paper
• B-cell hyperactivity in primary Sjögren's syndrome

  2014cites this paper
• Ductal epithelial expression of Ro52 correlates with inflammation in salivary glands of patients with primary Sjögren's syndrome

  2014cites this paper
• Autoimmunity: break-through in the diagnosis and treatment of immune-mediated inflammatory diseases.

  2014cites this paper
• Common and Specific Associations of Anti-SSA/Ro60 and Anti-Ro52/TRIM21 Antibodies in Systemic Lupus Erythematosus

  2013cites this paper